In contrast, there was a clear trend towards inferior survival for patients in cluster A. One potential explanation could be the higher number of patients harboring a mutation in TP53, which has previously been associated with inferior outcome in MDS del5q [22]. Here, TP53 is linked to myelodysplastic syndrome.